Exosens Stock Drops 6.63% and Falls Below a Key Technical Threshold
Exosens stock significantly declined this Thursday, April 9, dropping 6.63% to 62.65 euros by mid-morning, after closing at 67.10 euros the previous day. This downturn occurs amidst a general weakness in European markets, with the CAC 40 down 0.72% during the session at 8,204.70 points.
Today's drop in Exosens stock has caused the price to fall below its 20-day moving average, currently at 65.47 euros, whereas it had been trading above this level in previous sessions. This downward crossing is a sign of short-term vulnerability. The stock is now in the lower part of its Bollinger Bands, at 34% of the range between the lower bound at 56.45 euros and the upper bound at 74.49 euros, indicating selling pressure without yet reaching an oversold zone. Despite this correction, the stock remains above its 50-day moving average (60.93 euros), which could serve as a first stabilization level. The identified technical support is at 57.50 euros. Over a longer horizon, the performance remains strong with an increase of nearly 100% over one year and 13% over three months, supported by a price significantly higher than the 200-day moving average (48.50 euros).
Exosens Decline Part of a Broader Market Correction
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Exosens' decline is part of a broader correction affecting technology and industrial stocks listed in Europe. During the session, ASML Holding is down 1.42% and Schneider Electric drops 1.09%, two stocks similar to the profile of the French optronics and detection specialist. The SBF 120, which includes Exosens, is down 0.68% at the same time. The market context remains marked by a high level of tension, with the VIX standing at 25.78 points, up 6.66% from its last available value. It is worth noting that the publication of Exosens' first quarter 2026 results is expected on April 27, an event that could provide new insights into the group's trajectory. The general assembly is scheduled for May 22.
Porté par une dynamique commerciale soutenue, en particulier sur les marchés de la Défense et de la Surveillance, ainsi que par une solide exécution opérationnelle
Risks mentioned
Charge de dépréciation de la marque de 28,2 M€ pesant sur le résultat net publié, en baisse de 45,0 %
Incertitudes persistantes sur la recherche scientifique pesant sur la demande en Sciences de la Vie
Contraction de 60 points de base de la marge brute du segment Détection & Imagerie (mix produits)
Opportunities identified
Attribution par l'US Army du contrat IDIQ BiNOD ouvrant le marché américain de la défense
Plan d'expansion de +40 % des capacités de production d'ici 2027, premiers bénéfices au S2 2026
Acquisition d'Emberion, capteurs infrarouges SWIR à points quantiques
Outlook / guidance
Expected revenue: 530 millions d'euros
Expected EBITDA: 173 millions d'euros
Management commentary: chiffre d'affaires compris entre 520 millions d'euros et 540 millions d'euros ; • EBITDA ajusté compris entre 168 millions d'euros et 178 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
